These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34448549)

  • 1. Symptomatic and full remission rates in first-episode psychosis: A 12-month follow-up study in Korea.
    Kang SH; Piao YH; Li L; Kim SW; Kim JJ; Lee BJ; Yu JC; Lee KY; Won SH; Lee SH; Kim SH; Kim E; Rami FZ; Chung YC
    Early Interv Psychiatry; 2022 Jul; 16(7):760-769. PubMed ID: 34448549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of remission and recovery in young people presenting with first-episode psychosis in Hong Kong: a 3-year follow-up study.
    Chang WC; Tang JY; Hui CL; Lam MM; Chan SK; Wong GH; Chiu CP; Chen EY
    Aust N Z J Psychiatry; 2012 Feb; 46(2):100-8. PubMed ID: 22311526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of and time to symptomatic remission in first-episode psychosis in Northern Malawi: A STROBE-compliant article.
    Kaminga AC; Dai W; Liu A; Myaba J; Banda R; Wen SW; Pan X
    Medicine (Baltimore); 2018 Nov; 97(45):e13078. PubMed ID: 30407306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptomatic and functional remission in patients with first-episode psychosis.
    Verma S; Subramaniam M; Abdin E; Poon LY; Chong SA
    Acta Psychiatr Scand; 2012 Oct; 126(4):282-9. PubMed ID: 22616617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Road to full recovery: longitudinal relationship between symptomatic remission and psychosocial recovery in first-episode psychosis over 7.5 years.
    Álvarez-Jiménez M; Gleeson JF; Henry LP; Harrigan SM; Harris MG; Killackey E; Bendall S; Amminger GP; Yung AR; Herrman H; Jackson HJ; McGorry PD
    Psychol Med; 2012 Mar; 42(3):595-606. PubMed ID: 21854682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis.
    Ottesen A; T V Hegelstad W; Joa I; Opjordsmoen SE; Rund BR; Røssberg JI; Simonsen E; Johannessen JO; Larsen TK; Haahr UH; McGlashan TH; Friis S; Melle I
    Psychol Med; 2023 Apr; 53(6):2399-2408. PubMed ID: 37144963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent vs. adult onset of a first episode psychosis: Impact on remission of positive and negative symptoms.
    Veru F; Jordan G; Joober R; Malla A; Iyer S
    Schizophr Res; 2016 Jul; 174(1-3):183-188. PubMed ID: 27102425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective relationship between duration of untreated psychosis and 13-year clinical outcome: a first-episode psychosis study.
    Tang JY; Chang WC; Hui CL; Wong GH; Chan SK; Lee EH; Yeung WS; Wong CK; Tang WN; Chan WF; Pang EP; Tso S; Ng RM; Hung SF; Dunn EL; Sham PC; Chen EY
    Schizophr Res; 2014 Mar; 153(1-3):1-8. PubMed ID: 24529612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting one-year outcome in first episode psychosis using machine learning.
    Leighton SP; Krishnadas R; Chung K; Blair A; Brown S; Clark S; Sowerbutts K; Schwannauer M; Cavanagh J; Gumley AI
    PLoS One; 2019; 14(3):e0212846. PubMed ID: 30845268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of untreated psychosis predicts treatment outcome in an early psychosis program.
    Black K; Peters L; Rui Q; Milliken H; Whitehorn D; Kopala LC
    Schizophr Res; 2001 Mar; 47(2-3):215-22. PubMed ID: 11278138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of duration of untreated psychosis in short-term response to treatment and outcome in antipsychotic naïve first-episode psychosis.
    Cavalcante DA; Coutinho LS; Ortiz BB; Noto MN; Cordeiro Q; Ota VK; Belangeiro SI; Bressan RA; Gadelha A; Noto C
    Early Interv Psychiatry; 2020 Dec; 14(6):677-683. PubMed ID: 31637865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
    O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
    Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of untreated psychosis and acute remission of negative symptoms in a South American first-episode psychosis cohort.
    González-Valderrama A; Castañeda CP; Mena C; Undurraga J; Mondaca P; Yañez M; Bedregal P; Nachar R
    Early Interv Psychiatry; 2017 Feb; 11(1):77-82. PubMed ID: 26256570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of symptomatic remission in first-episode psychosis outpatients treated with quetiapine: a naturalistic study.
    Gade K; Köhler J; Klein P; Falkai P; Wobrock T
    Int J Psychiatry Clin Pract; 2013 Jun; 17(2):148-53. PubMed ID: 22746987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rates and predictors of 18-months remission in an epidemiological cohort of 661 patients with first-episode psychosis.
    Conus P; Cotton S; Schimmelmann BG; McGorry PD; Lambert M
    Soc Psychiatry Psychiatr Epidemiol; 2017 Sep; 52(9):1089-1099. PubMed ID: 28477070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between bullying and symptom presentation in first-episode psychosis.
    Kosteletos I; Hatzimanolis A; Xenaki LA; Ralli I; Dimitrakopoulos S; Vlahos I; Selakovic M; Foteli S; Soldatos RF; Nianiakas N; Kollias K; Stefanis N
    Psychiatriki; 2024 Mar; 35(1):17-25. PubMed ID: 37793035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between case management and longitudinal decrease in negative symptoms in patients with first episode psychosis: A 2-year follow-up.
    Pelizza L; Maestri D; Leuci E; Quattrone E; Azzali S; Paulillo G; Pellegrini P
    Early Interv Psychiatry; 2022 Nov; 16(11):1185-1191. PubMed ID: 35086160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of duration of untreated psychosis on pre-treatment, baseline, and outcome characteristics in an epidemiological first-episode psychosis cohort.
    Schimmelmann BG; Huber CG; Lambert M; Cotton S; McGorry PD; Conus P
    J Psychiatr Res; 2008 Oct; 42(12):982-90. PubMed ID: 18199456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.